Author:
Toumba Meropi,Skordis Nicos
Reference35 articles.
1. Arcasoy A, Ocal G, Kemahli S, Berberoğlu M, Yildirmak Y, Canatan D, Akçurin S, Akar N, Uysal Z, Adiyaman P, Cetinkaya E. Recombinant human growth hormone treatment in children with thalassemia major. Pediatr Int. 1999;41:655–61.
2. Caruso-Nicoletti M, De Sanctis V, Cavallo L, Raiola G, Ruggiero L, Skordis N, Wonke B. International workshop on management of puberty for optimum auxological results. Management of puberty for optimal auxological results in beta-thalassaemia major. J Pediatr Endocrinol Metab. 2001;14 Suppl 2:939–44.
3. Cavallo L, De Sanctis V, Cisternino M, Caruso Nicoletti M, Galati MC, Acquafredda A, Zecchino C, Delvecchio M. Final height in short poly-transfused thalassemia major patients treated with recombinant growth hormone. J Endocrinol Invest. 2005;28:363–6.
4. Chrysis D, Alexandrides T, Koromantzou E, Vasilakos P, Kiess W, Kratsch J, Beratis N, Spiliotis B. Novel application of IGF-1 and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with b-thalassaemia. Clin Endocrinol. 2001;54:253–59.
5. De Luca G, Maggiolini M, Bria M, Caracciolo M, Giorno A, Salemo M, Marisco S, Lanzino M, Brancati C, Ando S. GH secretion in thalassaemia patients with short stature. Horm Res. 1995;44:158–63.